Clinical and Molecular Hepatology10.3350/cmh.2022.0348202329SupplS157-S170Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and futureTina Reinson, Ryan M. Buchanan, Christopher D. Byrne,,
Clinical and Molecular Hepatology10.3350/cmh.2022.0362202329SupplS150-S156Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developmentsSang Bong Ahn,,
Hepatology10.1002/hep.2273520084919-11Back to the future with noninvasive biomarkers of liver fibrosisIndra Neil Guha,
Yearbook of Gastroenterology10.1016/s0739-5930(08)70228-920072007281-283The NAFLD Fibrosis Score: A Noninvasive System That Identifies Liver Fibrosis in Patients with NAFLDG.A. Makar,
Current Pathobiology Reports10.1007/s40139-014-0061-z201424245-256Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future DirectionsDaniel L. Motola, Peter Caravan, Raymond T. Chung, Bryan C. Fuchs,,
Clinical Liver Disease10.1002/cld.634201795125-130Hepatic fibrosis scores and serum biomarkers in pediatric hepatologyDaniel H. Leung,
Liver Diseases10.1007/978-3-030-24432-3_362020427-441Noninvasive Biomarkers for Liver FibrosisGamal Shiha, Nasser Mousa
Clinical Liver Disease10.1002/cld.636201796134-137Putting it all together: Noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in adults and childrenNaim Alkhouri,
Metabolism Open10.1016/j.metop.2021.100158202213100158Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]David Bernstein, Alexander J. Kovalic,
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2023.03.0422023Noninvasive Assessment of Liver Fibrosis in NAFLDArun J. Sanyal, Laurent Castéra, Vincent Wai-Sun Wong,